Phyllis W Speiser
Affiliation: Long Island Jewish Medical Center
- Long-term consequences of childhood-onset congenital adrenal hyperplasiaPerrin C White
Division of Pediatric Endocrinology and Professor of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA
Best Pract Res Clin Endocrinol Metab 16:273-88. 2002..This chapter addresses issues relating to long-term consequences in adult life of CAH-21OHD diagnosed in early childhood or adolescence...
- Impaired glucose tolerance in obese children and adolescentsPhyllis W Speiser
N Engl J Med 347:290-2; author reply 290-2. 2002
- Interpretation of pediatric endocrine laboratory tests: pitfalls in steroid hormone measurements and genotypingPhyllis W Speiser
New York University School of Medicine, New York, NY 10016, USA
Pediatr Endocrinol Rev 5:578-83. 2007..This article will provide guidance to the pediatric endocrinologist and to the primary care provider in better understanding the selection and interpretation of laboratory tests...
- Nonclassic adrenal hyperplasiaPhyllis W Speiser
Schneider Children s Hospital, 269 01 76th Ave, New Hyde Park, NY 11040, USA
Rev Endocr Metab Disord 10:77-82. 2009..This article will review relevant clinical, hormonal and genetic aspects of nonclassic adrenal hyperplasia...
- Bisphosphonate treatment of pediatric bone diseasePhyllis W Speiser
Schneider Children s Hospital and New York University School of Medicine, New Hyde Park, NY 11040, USA
Pediatr Endocrinol Rev 3:87-96. 2005....
- Childhood obesityPhyllis W Speiser
Division of Pediatric Endocrinology, Schneider Children s Hospital, 269 01 76th Avenue, New Hyde Park, New York 11040, USA
J Clin Endocrinol Metab 90:1871-87. 2005..In developing a consensus statement, this international group has presented the evidence, developed recommendations, and provided a platform aimed toward future corrective action and ongoing debate in the international community...
- Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasiaPhyllis W Speiser
Pediatric Endocrinology, Schneider Children s Hospital, New York University, New Hyde Park, NY 11040, USA
Horm Res 68:90-2. 2007..This article briefly reviews the prenatal and neonatal diagnosis of CAH caused by steroid 21-hydroxylase deficiency, as well as treatment options and neonatal screening approaches...
- Congenital adrenal hyperplasiaPhyllis W Speiser
Department of Pediatrics, Schneider Children s Hospital North Shore Long Island Jewish Health System, New Hyde Park, NY 11042, USA
N Engl J Med 349:776-88. 2003
- Continuous glucose monitoring in managing diabetes in childrenPhyllis W Speiser
Division of Pediatric Endocrinology, Schneider Children s Hospital, New Hyde Park, NY 11042, USA
Diabetes Metab Res Rev 18:330-1. 2002..Finally, this procedure has potential applications in the diagnosis and management of patients with other metabolic disorders...
- Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school childrenClaudia Boucher-Berry
Department of Pediatrics, Division of Pediatric Endocrinology, Cohen Children s Medical Center, New Hyde Park, NY 11040, USA
J Bone Miner Res 27:283-93. 2012..These findings are consistent with the hypothesis that markers of calcium and bone metabolism may reflect risk for adiposity-related comorbidities in children...
- Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelinePhyllis W Speiser
Cohen Children s Medical Center of New York and Hofstra University School of Medicine, New Hyde Park, New York 11040, USA
J Clin Endocrinol Metab 95:4133-60. 2010..We developed clinical practice guidelines for congenital adrenal hyperplasia (CAH)...
- Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in childrenRushika Conroy
Division of Pediatrics Endocrinology, Children s Hospita of New York, Presbyterian Hospital Columbia University Medical Center, New York, NY 10032, USA
J Pediatr Endocrinol Metab 24:913-9. 2011..This study examined the relationship between RBP4 and risk factors for co-morbidities of adiposity in a population of ethnically diverse children in early- to mid-adolescence in the public school system of New York City...
- Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetesAngela Delaney
Division of Pediatric Endocrinology, Schneider Children s Hospital, North Shore Long Island Jewish Health System, New Hyde Park, New York, USA
Diabetes Care 32:165-8. 2009....
- Congenital adrenal hyperplasia: an update in childrenChristine M Trapp
Division of Pediatric Endocrinology, Children s Hospital of New York Presbyterian, Columbia University College of Physicians and Surgeons, New York 10032, USA
Curr Opin Endocrinol Diabetes Obes 18:166-70. 2011....
- Treatment outcomes in congenital adrenal hyperplasiaTina Q Cheng
Division of Pediatric Endocrinology, Cohen Children s Medical Center of New York, New Hyde Park, 11040, USA
Adv Pediatr 59:269-81. 2012..Future advances may be recognized in the form of more efficient diagnostic tools, physiologic drug delivery, improved surgical methods, and assisted reproductive technologies...
- Poor glycemic control is associated with abnormal changes in 24-hour ambulatory blood pressure in children and adolescents with type 1 diabetes mellitusManjula Chatterjee
Division of Pediatric Endocrinology, Schneider Children s Hospital, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA
J Pediatr Endocrinol Metab 22:1061-7. 2009..Hypertension (HTN) is an important risk factor for, and may be an important indicator of diabetic nephropathy. Early accurate identification of HTN in DM1 may improve outcomes...
- Sex steroid hormones, growth and puberty in children with portal hypertensionCynthia M Yuse-Gabriel
Division of Pediatric Endocrinology, Schneider Children s Hospital of North Shore Long Island Jewish Health System, New Hyde Park, NY, USA
J Pediatr Endocrinol Metab 17:607-13. 2004..We conclude from this cross-sectional study that children with portal hypertension do not have clinical evidence of growth failure or abnormal puberty, despite subtle changes in the growth axis...
- Safety of medications and hormones used in pediatric endocrinology: adrenalGraeme R Frank
Schneider Children s Hospital, New Hyde Park, NY 11040, and New York University School of Medicine, USA
Pediatr Endocrinol Rev 2:134-45. 2004..This article also discusses the use of several inhibitors of adrenal steroid biosynthesis and one glucocorticoid receptor antagonist for the medical treatment of Cushing syndrome...
- Pamidronate treatment of hypercalcemia caused by vitamin D toxicityManjula Chatterjee
Division of Pediatric Endocrinology, Schneider Children s Hospital, New Hyde Park, NY 11040, USA
J Pediatr Endocrinol Metab 20:1241-8. 2007..This case highlights the potential danger of high dose vitamin supplements in children, and the salutary effects of treatment with bisphosphonate...
- Improving neonatal screening for congenital adrenal hyperplasiaPhyllis W Speiser
J Clin Endocrinol Metab 89:3685-6. 2004
- Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine SocietyPeter E Clayton
Horm Res 58:188-95. 2002
- Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiencyPhyllis W Speiser
J Clin Endocrinol Metab 87:3029-30. 2002